• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.

Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept. 2007 Apr 05; 140(1-2):12-20.

View in: PubMed

subject areas
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Apoptosis
  • Blotting, Western
  • Bradykinin
  • Cell Nucleus
  • Chemokine CCL2
  • Electrophoretic Mobility Shift Assay
  • Gene Expression Regulation
  • Inflammation
  • JNK Mitogen-Activated Protein Kinases
  • Male
  • Mitogen-Activated Protein Kinases
  • Myocardial Infarction
  • Myocytes, Cardiac
  • NF-kappa B
  • Oxidative Stress
  • Phosphorylation
  • Polymerase Chain Reaction
  • Protein Transport
  • Rats
  • Rats, Wistar
  • Tissue Kallikreins
  • Vascular Cell Adhesion Molecule-1
  • Ventricular Remodeling

authors with profiles
  • Julie Chao
  • Lee Chao